DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO. Stock

Certificat

DE000ME7TXS8

Market Closed - Börse Stuttgart 12:02:37 2024-05-31 EDT
190.6 EUR +0.38% Intraday chart for DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO.
Current month-0.97%
1 month-0.97%
Date Price Change
24-05-31 190.6 +0.38%
24-05-30 189.8 +0.03%
24-05-29 189.8 +0.25%
24-05-28 189.3 -0.18%
24-05-27 189.6 -0.25%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 12:02 pm

More quotes

Static data

Product typeDiscount Certificates
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN ME7TXS
ISINDE000ME7TXS8
Date issued 2024-01-29
Maturity 2024-12-20 (203 Days)
Parity 1 : 1
Emission price 190.1
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 194.3
Lowest since issue 185.8
Spread 0.08
Spread %0.04%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
232 USD
Average target price
278.7 USD
Spread / Average Target
+20.14%
Consensus